Neuralink has announced a backlog of 10,000 patients eager to receive its brain implant technology, highlighting significant interest and demand for the company's innovations in neurotechnology. The firm is working to navigate regulatory hurdles as it aims to expand its clinical trials and bring the implant to market.
neuralink ✓
brain-implant ✓
neurotechnology ✓
clinical-trials ✓
patient-demand ✓